USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE
摘要
<p>Drug products for use in treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.</p>
申请公布号
HK1119578(A1)
申请公布日期
2010.02.05
申请号
HK20080111743
申请日期
2008.10.24
申请人
SCHERING CORPORATION;THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASHEALTH AND HUMAN SERVICESREPRESENTED BY THESECRETARY OF THE DEPARTMENT OF H
发明人
CUA, DANIEL J.;KASTELEIN, ROBERT A.;TSAI, VAN T.;CASPI, RACHEL;SILVER, PHYLLIS;LUGER, DROR
